While additional work is needed to confirm these predictions, we foresee that further understanding the relationship between the p53 mutation and the altered regulatory mechanisms, could enhance our knowledge of ovarian carcinogenesis and the implementation of precision cancer medicine. This evidence concerns the gene TP53 and cancer.